Immuneinflamatory response in Staphylococcus aureus forunculosis
Keywords:
Genetic susceptibility, immune response, immunoinflammatory response, Staphylococcus aureus, anthrax, furunculosisDownloads
References
1.Matthew L, Mattappallil A, Finkel D, Parker D. Clinical impact of Staphylococcus aureus Skin and Soft Tissue Infections. Antibiotics (Basel) [Internet]. 2023 [citado 25/05/2023];12(3):557. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044708/. https://doi.org/10.3390/antibiotics12030557
2.Cella E, Sutcliffe CG, Tso C, Paul E, Ritchie N, Colelay J,et al. Carriage prevalence and genomic epidemiology of Staphylococcus aureus among Native American children and adults in the Southwestern USA. Microb Genom [Internet]. 2022 [citado 25/05/2023];8(5):mgen000806. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465076/. https://doi.org/10.1099/mgen.0.000806
3.Ricardo-Mora E, Álvarez-Yabor VJ, Ramírez-Hidalgo Y. Características clínicas y epidemiológicas en pacientes con piodermitis atendidos en un hospital general. Rev Electrón Dr. Zoilo E Marinello Vidaurreta [Internet]. 2019 [citado 15/06/2023];44(3):[aprox. 7 p.]. Disponible en: https://revzoilomarinello.sld.cu/index.php/zmv/article/view/1748/pdf_592
4.Hernández Moreno VJ, Rodríguez Rodríguez JA, Rodríguez Vera CM, Herrera Martínez M, Pérez Martín O. Comportamiento de la IgE y las subclases de IgG en las infecciones por Staphylococcus aureus.Medicentro Electrónica [Internet]. 2022 [citado 23/05/2023];26(3):583-597. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432022000300583
5.Søreide K. Impact of Microbial Infections on the Human Epigenome and Carcinogenesis. En: Handbook of Epigenetics. The New Molecular and Medical Genetics. 1st ed. Cambridge: Academic Press; 2010 [citado 23/05/2023]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/B9780123757098000290. https://doi.org/10.1016/B978-0-12-375709-8.00029-0
6.del Carpio Orantes L, García Méndez S, Hernández Hernández SN. Índices neutrófilo/linfocito, plaqueta/linfocito e inmunidad/inflamación sistémica en pacientes con neumonía por COVID-19. Gac Méd Méx [Internet]. 2020 [citado 15/06/2023];156:537-541. Disponible en: https://www.scielo.org.mx/pdf/gmm/v156n6/0016-3813-gmm-156-6-537.pdf. https://doi.org/10.24875/gmm.20000485
7.Lagunas-Alvarado M, Mijangos-Huesca FJ, Terán-González JO, Lagunas-Alvarado MG, Martínez-Zavala N, Reyes-Franco I, et al. Índice de inmunidad-inflamación sistémica en sepsis. Med Interna Méx [Internet]. 2017 [citado 07/06/2023];33(3):303-309. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662017000300303
8.Ali R, Weuscher L, Dona K, Worth R. Platelets mediate host-defense against S. aureus through direct bactericidal activity and by enhancing macrophage activities. J Immunol [Internet]. 2016 [citado 05/06/2023];196(1_Supplement):200.12. Disponible en: https://journals.aai.org/jimmunol/article/196/1_Supplement/200.12/76837. https://doi.org/10.4049/jimmunol.196.Supp.200.12
9.Waller AK, Birch K, Gibbins JM,Clarke SR. Activation of Human Platelets by Staphylococcus aureus Secreted Protease Staphopain A. Pathogens [Internet]. 2022 [citado 06/06/2023];11(11):1237. Disponible en: https://www.mdpi.com/2076-0817/11/11/1237. https://doi.org/10.3390/pathogens11111237
10.Wolff M, Handtke S, Palankar R, Wesche J, Kohler T, Kohler C,et al. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies. J Thromb Haemost [Internet]. 2020 [citado 15/06/2023];18(6):1459-1468. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32237268/. https://doi.org/10.1111/jth.14814
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).